Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and PSA in prostate cancer patients receiving radium-223 dichloride therapy.

被引：0
|
作者：
Nakagami, Y. [1 ]
Kano, D. [1 ]
Kusumoto, M. [1 ]
机构：
[1] Natl Canc Ctr, Chiba, Japan
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P747
引用
收藏
页码：S698 / S699
页数：2
相关论文
共 50 条
  • [1] Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases
    Wakabayashi, Hiroshi
    Nakajima, Kenichi
    Mizokami, Atsushi
    Namiki, Mikio
    Inaki, Anri
    Taki, Junichi
    Kinuya, Seigo
    ANNALS OF NUCLEAR MEDICINE, 2013, 27 (09) : 802 - 807
  • [2] Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases
    Hiroshi Wakabayashi
    Kenichi Nakajima
    Atsushi Mizokami
    Mikio Namiki
    Anri Inaki
    Junichi Taki
    Seigo Kinuya
    Annals of Nuclear Medicine, 2013, 27 : 802 - 807
  • [3] Can bone scans guide therapy with radium-223 dichloride for prostate cancer bone metastases?
    Gayed, Isis
    Salama, Vivian
    Dawood, Lydia
    Canfield, Steven
    Wan, David
    Cai, Chunyan
    Joseph, Usha
    Amato, Robert
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 3317 - 3324
  • [4] Radium-223 Therapy of Bone Metastases in Prostate Cancer
    Nilsson, Sten
    SEMINARS IN NUCLEAR MEDICINE, 2016, 46 (06) : 544 - 556
  • [5] Automatic bone scan index for therapy response assessment of radium-223-dichloride (Ra-223) therapy in advanced prostate cancer
    Sakretz, M.
    Kurth, J.
    Schwarzenboeck, S. M.
    Krause, B. J.
    Heuschkel, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S699 - S699
  • [6] Bone scan index can be a useful biomarker of survival outcomes in patients with metastatic castration-resistant prostate cancer treated with radium-223
    Naito, Miki
    Ukai, Rinzo
    Hashimoto, Kunihiro
    CANCER REPORTS, 2019, 2 (05)
  • [7] Mechanisms of Bone Marrow Failure in Prostate Cancer Patients treated with Radium-223 Therapy
    Fiz, F.
    Campl, C.
    Sahbai, S.
    Schwanck, J.
    Weissinger, M.
    Bauckneht, M.
    Piva, R.
    Marini, C.
    Dittman, H.
    Piana, M.
    Sambuceti, G.
    La Fougere, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S329 - S330
  • [8] Is There a Flare Phenomenon on Bone Scintigraphy in Men With Advanced Prostate Cancer Treated With Radium-223?
    Isensee, Gesa
    Peporte, Anne
    Mueller, Joachim
    Schmid, Sabine
    Gillessen, Silke
    Omlin, Aurelius
    CLINICAL GENITOURINARY CANCER, 2018, 16 (05) : 349 - 354
  • [9] Combined bone scintigraphy and fluorocholine PET/computed tomography predicts response to radium-223 therapy in patients with prostate cancer
    Klain, Michele
    Gaudieri, Valeria
    Petretta, Mario
    Zampella, Emilia
    Storto, Giovanni
    Nappi, Carmela
    Buonerba, Carlo
    Crocetto, Felice
    Gallicchio, Rosj
    Volpe, Fabio
    Pace, Leonardo
    Schlumberger, Martin
    Cuocolo, Alberto
    FUTURE SCIENCE OA, 2021, 7 (08):
  • [10] Automated bone scan index as an imaging biomarker in metastatic castration resistant prostate cancer (mCRPC) patients treated with radium-223.
    Anand, Aseem
    Daignault, Stephanie
    Nordquist, Luke T.
    Ramos, Jorge
    Jain, Rohit K.
    McDonald, Matthew
    Campbell, Gregory
    George, Saby
    Albany, Costantine
    Yu, Evan Y.
    Bjartell, Anders
    Alva, Ajjai Shivaram
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345